Insider filing · RAPP
Cheryl Gault
Chief Operating Officer
profile →
Rapport Therapeutics, Inc.
RAPP · Healthcare · 38 filings in 24 months
ticker →
Cheryl Gault sold $262K of Rapport Therapeutics (RAPP)
Executed Sep 30, disclosed Oct 1, 1 day later.
Value, as filed
$262K
7,925 sh × $33.04
Executed
Sep 30
the trade date, as filed
Disclosed
Oct 1
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
CGCheryl Gault (Chief Operating Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Rapport Therapeutics, Inc. (RAPP). The largest single filing was $296K of RAPP (7,100 sh across 2 lots, as filed), executed Jun 30.
The name
RAPPHealthcare · Rapport Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transfo…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Cheryl Gault in RAPP
RAPPSALE
Rapport Therapeutics, Inc.
$296K7,100 sh across 2 lots
Exec Jun 30
Filed Jul 1 · 4:10 PM ET RAPPSALE Rapport Therapeutics, Inc. $201K
7,161 sh × $28.04
Exec Mar 30
Filed Mar 31 · 5:30 PM ET RAPPSALE Rapport Therapeutics, Inc. $150K
5,000 sh × $30.10
Exec Nov 26 2025
Filed Dec 1 2025 · 5:30 PM ET RAPPSALE Rapport Therapeutics, Inc. $192K
5,000 sh × $38.33
Exec Sep 8 2025
Filed Sep 10 2025 · 5:30 PM ET